C07K 14/8139
Cysteine protease inhibitors
Official title: {Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin}
C07K14/8139 (Cysteine protease inhibitors) appears on 133 US grants and 160 published applications in this corpus.
Search patents in C07K- Granted patents
- 133
- Published applications
- 160
- Assignees
- 141
- Inventors
- 437
- Latest grant
- 3 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 6 | 0 |
| 1998 | 2 | 0 |
| 1999 | 11 | 0 |
| 2000 | 8 | 0 |
| 2001 | 8 | 1 |
| 2002 | 3 | 12 |
| 2003 | 7 | 17 |
| 2004 | 5 | 13 |
| 2005 | 4 | 7 |
| 2006 | 4 | 4 |
| 2007 | 6 | 9 |
| 2008 | 3 | 2 |
| 2009 | 3 | 4 |
| 2010 | 4 | 5 |
| 2011 | 3 | 6 |
| 2012 | 2 | 8 |
| 2013 | 3 | 3 |
| 2014 | 5 | 6 |
| 2015 | 3 | 7 |
| 2016 | 4 | 3 |
| 2017 | 5 | 8 |
| 2018 | 3 | 2 |
| 2019 | 3 | 3 |
| 2020 | 2 | 5 |
| 2021 | 2 | 2 |
| 2022 | 0 | 7 |
| 2023 | 1 | 4 |
| 2024 | 6 | 11 |
| 2025 | 4 | 8 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Therapeutic nanoconjugates comprising Stefin A and uses thereof3 Feb 2026US 12,540,172 B2Consorcio Centro de Investigación Biomédica en Red, M. P.
- Compositions and methods for measuring and inhibiting calpain-5 activity2 Dec 2025US 12,486,528 B2The Board of Trustees of the Leland Stanford Junior University
- Polypeptide having effect of inhibiting proliferation of leukemia cells19 Aug 2025US 12,391,735 B2
- Methods and compositions for the detection and diagnosis of renal disease and periodontal disease12 Aug 2025US 12,385,927 B2IDEXX Laboratories, Inc.
- Scaffold proteins29 Apr 2025US 12,286,468 B2Avacta Life Sciences Limited
- Therapeutic targeting of tumor escape by car-mediated trogocytosis20 Aug 2026US 2026/0241002 A1University of Maryland, Baltimore
- Genetically modified cells comprising a nucleic acid encoding a cd40l binding agent and uses thereof22 Jan 2026US 2026/0022160 A1AffyXell Therapeutics Co., Ltd.
- Genetically modified cells comprising a nucleic acid encoding a cd40l binding agent and uses thereof22 Jan 2026US 2026/0022343 A1AffyXell Therapeutics Co., Ltd.
- Methods and compositions for the detection and diagnosis of renal disease and periodontal disease6 Nov 2025US 2025/0341529 A1IDEXX Laboratories, Inc.
- Scaffold proteins28 Aug 2025US 2025/0270293 A1Avacta Life Sciences Limited
Most cited
By later US patents
- Oil-body proteins as carriers of high-value peptides in plants136US 5,650,554 ASemBioSys Genetics Inc. · 1997
- Preparation of heterologous proteins on oil bodies101US 5,948,682 ASemBioSys Genetics Inc. · 1999
- Preparation of heterologous proteins on oil bodies92US 6,753,167 B2SemBioSys Genetics Inc. · 2004
- ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting80US 5,340,736 APresident and Fellows of Harvard College · 1994
- Germination-specific plant promoters34US 6,359,196 B12002